Tumor suppression using human placental perfusate and human placentaderived intermediate natural killer cells

Details for Australian Patent Application No. 2008307633 (hide)

Owner Celgene Cellular Therapeutics

Inventors Voskinarian-Berse, Vanessa A.; Kang, Lin; Padliya, Neerav Dilip; Zhang, Xiaokui

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008307633

PCT Pub. Number WO2009/045360

Priority 61/090,555 20.08.08 US; 60/995,763 28.09.07 US

Filing date 29 September 2008

Wipo publication date 9 April 2009

International Classifications

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 35/50 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/07 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells or tissues

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/045360 Priority application(s): WO2009/045360

12 May 2011 Alteration of Name

  The name of the applicant has been altered to Anthrogenesis Corporation

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008307634-Biological markers predictive of anticancer response to insulin-like growth factor-1 receptor kinase inhibitors

2008307631-Portable air pulsator and thoracic therapy garment